glycine has been researched along with Movement Disorders in 23 studies
Movement Disorders: Syndromes which feature DYSKINESIAS as a cardinal manifestation of the disease process. Included in this category are degenerative, hereditary, post-infectious, medication-induced, post-inflammatory, and post-traumatic conditions.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We performed a therapeutic trial with the glycine precursor, milacemide, on 10 patients with intractable movement disorders." | 9.07 | Therapeutic trial of milacemide in patients with myoclonus and other intractable movement disorders. ( Diaz-Olivo, R; Fahn, S; Gordon, MF; Hunt, AL, 1993) |
| "We performed a therapeutic trial with the glycine precursor, milacemide, on 10 patients with intractable movement disorders." | 5.07 | Therapeutic trial of milacemide in patients with myoclonus and other intractable movement disorders. ( Diaz-Olivo, R; Fahn, S; Gordon, MF; Hunt, AL, 1993) |
| "Glycine has important neurotransmitter functions at inhibitory and excitatory synapses in the vertebrate central nervous system." | 2.43 | Glycine transporters: essential regulators of neurotransmission. ( Armsen, W; Betz, H; Eulenburg, V; Gomeza, J, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (21.74) | 18.7374 |
| 1990's | 3 (13.04) | 18.2507 |
| 2000's | 5 (21.74) | 29.6817 |
| 2010's | 9 (39.13) | 24.3611 |
| 2020's | 1 (4.35) | 2.80 |
| Authors | Studies |
|---|---|
| Balestrino, M | 1 |
| Adriano, E | 1 |
| Mirelman, A | 1 |
| Saunders-Pullman, R | 1 |
| Alcalay, RN | 1 |
| Shustak, S | 1 |
| Thaler, A | 1 |
| Gurevich, T | 1 |
| Raymond, D | 1 |
| Mejia-Santana, H | 1 |
| Orbe Reilly, M | 1 |
| Ozelius, L | 1 |
| Clark, L | 1 |
| Gana-Weisz, M | 1 |
| Bar-Shira, A | 1 |
| Orr-Utreger, A | 1 |
| Bressman, SB | 1 |
| Marder, K | 1 |
| Giladi, N | 1 |
| Benoit, R | 1 |
| Samir, M | 1 |
| Boutin, J | 1 |
| Samuel, A | 1 |
| Brigitte, C | 1 |
| Dominique, D | 1 |
| Isabelle, RV | 1 |
| El-Gharbawy, AH | 1 |
| Goldstein, JL | 1 |
| Millington, DS | 1 |
| Vaisnins, AE | 1 |
| Schlune, A | 2 |
| Barshop, BA | 1 |
| Schulze, A | 4 |
| Koeberl, DD | 1 |
| Young, SP | 1 |
| Stockler-Ipsiroglu, S | 1 |
| van Karnebeek, C | 1 |
| Longo, N | 2 |
| Korenke, GC | 1 |
| Mercimek-Mahmutoglu, S | 2 |
| Marquart, I | 1 |
| Barshop, B | 1 |
| Grolik, C | 2 |
| Angle, B | 1 |
| Araújo, HC | 2 |
| Coskun, T | 1 |
| Diogo, L | 1 |
| Geraghty, M | 1 |
| Haliloglu, G | 1 |
| Konstantopoulou, V | 1 |
| Leuzzi, V | 2 |
| Levtova, A | 1 |
| Mackenzie, J | 1 |
| Maranda, B | 1 |
| Mhanni, AA | 1 |
| Mitchell, G | 1 |
| Morris, A | 1 |
| Newlove, T | 1 |
| Renaud, D | 1 |
| Scaglia, F | 1 |
| Valayannopoulos, V | 1 |
| van Spronsen, FJ | 1 |
| Verbruggen, KT | 1 |
| Yuskiv, N | 1 |
| Nyhan, W | 1 |
| Braissant, O | 2 |
| Pasquali, M | 1 |
| Schwarz, E | 1 |
| Jensen, M | 1 |
| Yuzyuk, T | 1 |
| DeBiase, I | 1 |
| Randall, H | 1 |
| Pitt, JJ | 1 |
| Tzanakos, N | 1 |
| Nguyen, T | 1 |
| Tran, C | 1 |
| Levandovskiy, V | 1 |
| Patel, V | 1 |
| Cortez, MA | 1 |
| Byrnes, KR | 1 |
| Loane, DJ | 1 |
| Stoica, BA | 1 |
| Zhang, J | 1 |
| Faden, AI | 1 |
| Eulenburg, V | 1 |
| Armsen, W | 1 |
| Betz, H | 1 |
| Gomeza, J | 1 |
| Kay, DM | 1 |
| Zabetian, CP | 1 |
| Factor, SA | 1 |
| Nutt, JG | 1 |
| Samii, A | 1 |
| Griffith, A | 1 |
| Bird, TD | 1 |
| Kramer, P | 1 |
| Higgins, DS | 1 |
| Payami, H | 1 |
| Stoeckler-Ipsiroglu, S | 1 |
| Adami, A | 1 |
| Appleton, R | 1 |
| Duran, M | 1 |
| Ensenauer, R | 1 |
| Fernandez-Alvarez, E | 1 |
| Garcia, P | 1 |
| Item, CB | 1 |
| Marquardt, I | 1 |
| Mühl, A | 1 |
| Saelke-Kellermann, RA | 1 |
| Salomons, GS | 1 |
| Surtees, R | 1 |
| van der Knaap, MS | 1 |
| Vasconcelos, R | 1 |
| Verhoeven, NM | 1 |
| Vilarinho, L | 1 |
| Wilichowski, E | 1 |
| Jakobs, C | 1 |
| Henry, H | 1 |
| Gordon, MF | 1 |
| Diaz-Olivo, R | 1 |
| Hunt, AL | 1 |
| Fahn, S | 1 |
| Emery, ES | 1 |
| Homans, AC | 1 |
| Colletti, RB | 1 |
| Crone, C | 1 |
| Nielsen, J | 1 |
| Petersen, N | 1 |
| Tijssen, MA | 1 |
| van Dijk, JG | 1 |
| Becker, CM | 1 |
| Larson, AA | 1 |
| Davidoff, RA | 1 |
| Graham, LT | 1 |
| Shank, RP | 1 |
| Werman, R | 1 |
| Aprison, MH | 1 |
| Kastin, AJ | 1 |
| Barbeau, A | 1 |
| van der Zee, SP | 1 |
| Lommen, EJ | 1 |
| Trijbels, JM | 1 |
| Schretlen, ED | 1 |
| Ghadimi, H | 1 |
| Bhalla, CK | 1 |
| Kirchenbaum, DM | 1 |
3 reviews available for glycine and Movement Disorders
| Article | Year |
|---|---|
Glycine transporters: essential regulators of neurotransmission.
Topics: Amino Acid Transport Systems, Neutral; Animals; Glycine; Glycine Plasma Membrane Transport Proteins; | 2005 |
AGAT, GAMT and SLC6A8 distribution in the central nervous system, in relation to creatine deficiency syndromes: a review.
Topics: Amidinotransferases; Amino Acid Metabolism, Inborn Errors; Animals; Brain; Creatine; Developmental D | 2008 |
Disorders of the inhibitory glycine receptor: the spastic mouse.
Topics: Animals; Disease Models, Animal; Glycine; Humans; Mice; Mice, Neurologic Mutants; Movement Disorders | 1990 |
1 trial available for glycine and Movement Disorders
| Article | Year |
|---|---|
Therapeutic trial of milacemide in patients with myoclonus and other intractable movement disorders.
Topics: Acetamides; Administration, Oral; Adult; Aged; Basal Ganglia; Blood-Brain Barrier; Double-Blind Meth | 1993 |
19 other studies available for glycine and Movement Disorders
| Article | Year |
|---|---|
Presence of guanidinoacetate may compensate creatine absence and account for less statin-induced muscle damage in GAMT-deficient compared to AGAT-deficient mice.
Topics: Amidinotransferases; Amino Acid Metabolism, Inborn Errors; Animals; Creatine; Developmental Disabili | 2020 |
Application of the Movement Disorder Society prodromal criteria in healthy G2019S-LRRK2 carriers.
Topics: Adult; Aged; Aged, 80 and over; Female; Glycine; Humans; Leucine-Rich Repeat Serine-Threonine Protei | 2018 |
LC-MS/MS measurements of urinary guanidinoacetic acid and creatine: Method optimization by deleting derivatization step.
Topics: Chromatography, High Pressure Liquid; Clinical Laboratory Techniques; Creatine; Glycine; Guanidinoac | 2019 |
Elevation of guanidinoacetate in newborn dried blood spots and impact of early treatment in GAMT deficiency.
Topics: Case-Control Studies; Child, Preschool; Creatine; Dried Blood Spot Testing; Early Diagnosis; Female; | 2013 |
Guanidinoacetate methyltransferase (GAMT) deficiency: outcomes in 48 individuals and recommendations for diagnosis, treatment and monitoring.
Topics: Adolescent; Adult; Arginine; Brain; Child; Child, Preschool; Combined Modality Therapy; Creatine; Fe | 2014 |
GAMT deficiency: 20 years of a treatable inborn error of metabolism.
Topics: Arginine; Creatine; Female; Glycine; Guanidinoacetate N-Methyltransferase; Humans; Intellectual Disa | 2014 |
Feasibility of newborn screening for guanidinoacetate methyltransferase (GAMT) deficiency.
Topics: Brain; Creatine; Dried Blood Spot Testing; False Positive Reactions; Feasibility Studies; Glycine; G | 2014 |
Newborn screening for guanidinoacetate methyl transferase deficiency.
Topics: Arginine; Creatine; Diet; Female; Glycine; Guanidinoacetate N-Methyltransferase; Humans; Intellectua | 2014 |
Systemic availability of guanidinoacetate affects GABAA receptor function and seizure threshold in GAMT deficient mice.
Topics: Animals; Electrocorticography; Glycine; Guanidinoacetate N-Methyltransferase; Language Development D | 2016 |
Delayed mGluR5 activation limits neuroinflammation and neurodegeneration after traumatic brain injury.
Topics: Animals; Brain Injuries; Calcium-Binding Proteins; Cognition Disorders; Diffusion Tensor Imaging; Di | 2012 |
Parkinson's disease and LRRK2: frequency of a common mutation in U.S. movement disorder clinics.
Topics: Adolescent; Adult; Age of Onset; Aged; Aged, 80 and over; DNA Mutational Analysis; Family Health; Fe | 2006 |
GAMT deficiency: features, treatment, and outcome in an inborn error of creatine synthesis.
Topics: Adolescent; Adult; Child; Creatine; Epilepsy; Female; Glycine; Guanidinoacetate N-Methyltransferase; | 2006 |
Vitamin B12 deficiency: a cause of abnormal movements in infants.
Topics: Glycine; Humans; Infant; Male; Movement Disorders; Vitamin B 12 Deficiency | 1997 |
Patients with the major and minor form of hyperekplexia differ with regards to disynaptic reciprocal inhibition between ankle flexor and extensor muscles.
Topics: Adult; Ankle Joint; Electromyography; Glycine; H-Reflex; Humans; Middle Aged; Movement Disorders; Mu | 2001 |
Intrathecal GABA, glycine, taurine or beta-alanine elicits dyskinetic movements in mice.
Topics: Alanine; Animals; Dose-Response Relationship, Drug; gamma-Aminobutyric Acid; Glycine; Injections, In | 1989 |
Changes in amino acid concentrations associated with loss of spinal interneurons.
Topics: Aminobutyrates; Animals; Aorta, Thoracic; Aortic Valve Stenosis; Aspartic Acid; Cats; Freezing; Glut | 1967 |
Preliminary clinical studies with L-prolyl-L-leucyl-glycine amide in Parkinson's disease.
Topics: Administration, Oral; Aged; Amides; Antiparkinson Agents; Dihydroxyphenylalanine; Female; Glycine; H | 1972 |
The influence of adenine on the clinical features and purine metabolism in the Lesch-Nyhan syndrome.
Topics: Adenine; Allopurinol; Athetosis; Bone Marrow; Carbon Isotopes; Child; Child, Preschool; Chorea; Comp | 1970 |
The significance of the deficiency state in Lesch-Nyhan disease.
Topics: Allopurinol; Amino Acids; Athetosis; Carbon Isotopes; Child, Preschool; Chorea; Compulsive Behavior; | 1970 |